.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
Healthtrust
Deloitte
Colorcon
Cerilliant
Harvard Business School
Chubb
Daiichi Sankyo
US Army

Generated: February 25, 2018

DrugPatentWatch Database Preview

Mechanism of Action: Proteasome Inhibitors

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi UsaBORTEZOMIBbortezomibPOWDER;INTRAVENOUS205004-001Nov 6, 2017RXNoNo➤ Sign Up➤ Sign UpY➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-002Jun 3, 2016RXYesNo➤ Sign Up➤ Sign Up➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-002Jun 3, 2016RXYesNo➤ Sign Up➤ Sign UpYY➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-001Jul 20, 2012RXYesYes➤ Sign Up➤ Sign UpY➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-001Jul 20, 2012RXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-002Jun 3, 2016RXYesNo➤ Sign Up➤ Sign UpYY➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-001Jul 20, 2012RXYesYes➤ Sign Up➤ Sign UpYY➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-001Jul 20, 2012RXYesYes➤ Sign Up➤ Sign UpYY➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-001Jul 20, 2012RXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Onyx TherapKYPROLIScarfilzomibPOWDER;INTRAVENOUS202714-002Jun 3, 2016RXYesNo➤ Sign Up➤ Sign UpYY➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
McKesson
Citi
Merck
Colorcon
Harvard Business School
Johnson and Johnson
Moodys
Healthtrust
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot